Pamela A. Basto
Pamela A. Basto
PhD
Verified email at mit.edu
Title
Cited by
Cited by
Year
Microfluidic platform for controlled synthesis of polymeric nanoparticles
R Karnik, F Gu, P Basto, C Cannizzaro, L Dean, W Kyei-Manu, R Langer, ...
Nano letters 8 (9), 2906-2912, 2008
6212008
A vector-free microfluidic platform for intracellular delivery
A Sharei, J Zoldan, A Adamo, WY Sim, N Cho, E Jackson, S Mao, ...
Proceedings of the National Academy of Sciences 110 (6), 2082-2087, 2013
2962013
Co‐delivery of hydrophobic and hydrophilic drugs from nanoparticle–aptamer bioconjugates
L Zhang, AF Radovic‐Moreno, F Alexis, FX Gu, PA Basto, V Bagalkot, ...
ChemMedChem 2 (9), 1268-1271, 2007
2742007
Single-step assembly of homogenous lipid− polymeric and lipid− quantum dot nanoparticles enabled by microfluidic rapid mixing
PM Valencia, PA Basto, L Zhang, M Rhee, R Langer, OC Farokhzad, ...
ACS nano 4 (3), 1671-1679, 2010
2502010
A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells
G Stary, A Olive, AF Radovic-Moreno, D Gondek, D Alvarez, PA Basto, ...
Science 348 (6241), 2015
2182015
Engineered nanomedicine for myeloma and bone microenvironment targeting
A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ...
Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014
2072014
Poly (amino acid) targeting moieties
F Alexis, L Zhang, AF Radovic-Moreno, FX Gu, P Basto, ...
US Patent App. 12/098,354, 2009
1512009
HER-2 targeted nanoparticle-affibody bioconjugates for cancer therapy
F Alexis, P Basto, E Levy-Nissenbaum, AF Radovic-Moreno, L Zhang, ...
ChemMedChem 3 (12), 1839, 2008
1502008
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine …
PO Ilyinskii, CJ Roy, CP O’Neil, EA Browning, LA Pittet, DH Altreuter, ...
Vaccine 32 (24), 2882-2895, 2014
1272014
Vaccine nanotechnology
UH Von Andrian, OC Farokhzad, RS Langer, T Junt, EA Moseman, ...
US Patent 10,736,848, 2020
952020
Targeting of antigen presenting cells with immunonanotherapeutics
J Shi, F Alexis, M Iannacone, EA Moseman, P Basto, RS Langer, ...
US Patent 8,343,497, 2013
892013
Adjuvant incorporation in immunonanotherapeutics
F Alexis, M Iannacone, J Shi, P Basto, EA Moseman, U Von Andrian, ...
US Patent 8,343,498, 2013
872013
Microfluidic synthesis of organic nanoparticles
R Karnik, FX Gu, P Basto, C Cannizzaro, A Khademhosseini, RS Langer, ...
US Patent 9,381,477, 2016
832016
Vaccine nanotechnology
UH Von Andrian, OC Farokhzad, RS Langer, T Junt, EA Moseman, ...
US Patent 9,526,702, 2016
762016
Adjuvant incorporation in immunonanotherapeutics
F Alexis, M Iannacone, J Shi, P Basto, EA Moseman, U Von Andrian, ...
US Patent 8,637,028, 2014
732014
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
M Iannacone, F Alexis, P Basto, EA Moseman, J Shi, RS Langer, ...
US Patent 8,277,812, 2012
632012
Adjuvant incorporation in immunoanotherapeutics
F Alexis, M Iannacone, J Shi, P Basto, EA Moseman, U Von Andrian, ...
US Patent 9,439,859, 2016
572016
Nicotine immunonanotherapeutics
U Von Andrian, OC Farokhzad, F Alexis, M Iannacone, P Basto, J Shi, ...
US Patent 8,591,905, 2013
482013
Distribution of alkaline phosphatase, osteopontin, RANK ligand and osteoprotegerin in calcified human carotid atheroma
CL Higgins, S Isbilir, P Basto, IY Chen, M Vaduganathan, ...
The protein journal 34 (5), 315-328, 2015
312015
Nicotine immunonanotherapeutics
M Iannacone, U Von Andrian, OC Farokhzad, F Alexis, P Basto, J Shi, ...
US Patent 8,932,595, 2015
252015
The system can't perform the operation now. Try again later.
Articles 1–20